The Effect of Mental Fatigue on Upper Extremity Functional Performance

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorIzmir Bakircay University

About this trial

Mental fatigue (MF) is known to impair cognitive performance and may negatively affect physical performance. While its effects on lower-extremity functional performance have been investigated, little is known about the influence of MF on upper-extremity physical performance tests commonly used in sports and rehabilitation settings. This randomized crossover study will investigate the effects of experimentally induced mental fatigue on upper-extremity physical performance in 16 healthy physically active adults. Participants will complete both a mental fatigue condition, involving a prolonged Stroop task, and a control condition consisting of watching an emotionally neutral documentary. Before and after each condition, participants will perform the Upper Quarter Y Balance Test, Reactive Upper Quarter Y Balance Test, Closed Kinetic Chain Upper Extremity Stability Test, and Seated Single-Arm Shot Put Test. Subjective mental fatigue, cognitive performance, motivation, and perceived exertion will also be assessed. The findings will improve understanding of whether mental fatigue influences upper-extremity physical performance test outcomes and may assist clinicians and researchers in interpreting these assessments in sports medicine and rehabilitation contexts.

Eligibility criteria

Qualifiers

Age between 18 and 35 years

Healthy (no neurological, cardiovascular or musculoskeletal disorders of any kind)

Male or female

No prior knowledge of the concept of mental fatigue

Disqualifiers

Previous major upper limb injury (last 6 months)

Involvement in another concurrent physical or cognitive intervention study

Use of caffeine and heavy efforts 24 hours prior each trial

Suffering from colour vision deficiencies

Trial design

Treatments tested in this trial

  • Mental Fatigue

Treatment groups

16 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Izmir Bakircay University

Lead sponsor

Vrije Universiteit Brussel

Collaborator